Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 22246-13-5 | MDL No. : | MFCD00559318 |
Formula : | C9H10N2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NFWVCYWFUIFIKU-UHFFFAOYSA-N |
M.W : | 162.19 | Pubchem ID : | 4912759 |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
14 mg; 14 mg | Example 287: Preparation of 4-(cyclopropylamino)-2-((2-oxo-l,2,3,4-tetrahydroquinolin-6- yl)amino)pyrimidine-5-carbonitrile and 2-(cyclopropylamino)-4-((2-oxo-l,2,3>4- tetrahydroquinolin-6-yl)amino)pyrimidine-5-carbonitrile.2,4-Dichloropyrimidine-5-carbonitrile (0.100 g, 0.575 mmol), cyclopropanamine (0.040 ml, 0.575 mmol) and N-ethyl-N-isopropylpropan-2-amine (0.1 10 ml, 0.632 mmol) were mixed in acetonitrile (2 ml). The mixture was microwaved at 70 °C for 10 min and then concentrated. 6- amino-3,4-dihydroquinolin-2(l H)-one (0.093 g, 0.575 mmol) and acetic acid (0.035 g, 0.575 mmol) were added. The mixture was microwaved at 1 10 °C for 20 min and then concentrated. 14 mg of 4-(cyclopropylamino)-2-((2-oxo- l ,2,3,4-tetrahydroquinolin-6-yl)amino)pyrimidine-5- carbonitrile and 14 mg of 2-(cyclopropylamino)-4-((2-oxo-l ,2,3,4-tetrahydroquinolin-6- yl)amino)pyrimidine-5-carbonitrile were recovered after automated reverse phasechromatography (water-MeCN). MS calcd for [Ci7Hi6N60+H]+: 321.15 found 321.00. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | With N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; at 80℃; for 72h; | To a stirred solution of <strong>[475216-25-2]4-fluoro-N-methyl-3-nitrobenzamide</strong>2 (500 mg) in N-methyl-2- pyrrolidinone (5 ml) were added 6-amino-3,4-dihydroquinolin-2(iH)-one24 (450 mg) and N,Ndiisopropylethylamine (489 mg). The reaction mixture was heated at 80 C for 3 days. LC-MS analysis indicated that the reaction was incomplete. The reaction mixture was heated at 120 Cfor 1 day. The reaction mixture was cooled to room temperature and ethyl acetate (10 ml) and water (3 ml) were added. An orange precipitate formed. The precipitate was collected by filtration, washed with ethyl acetate, and dried in vacuo to give N-methyl-3-nitro-4-((2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)amino)benzamide as an orange solid (825 mg, 96 %). MS (ISP):341.0 ([M+H]j. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | With N-ethyl-N,N-diisopropylamine; HATU; In N,N-dimethyl-formamide; at 20℃; for 2h; | Into a 40- mL vial was placed a mixture of 6-amino-7-fluoro-3,4-dihydroquinolin-2(lH)-one (180 mg, 1.00 mmol, 1.00 equiv), N,N-dimethylformamide (5 mL), <strong>[4080-54-0]3-ethylisonicotinic acid</strong> (166 mg, 1.10 mmol, 1.10 equiv), N-ethyl-N-isopropylpropan-2-amine (387 mg, 3.00 mmol, 3.00 equiv) and l-((dimethylamino)(dimethyliminio)methyl)-lH-[l,2,3]triazolo[4,5-b]pyridine 3- oxide hexafluorophosphate(V) (570 mg, 1.50 mmol, 1.50 equiv). The reaction mixture was stirred for 2 hours at room temperature. The reaction mixture was filtered and the filtrate was purified by prep-HPLC. This resulted in 260 mg (88%) of 3-ethyl-N-(2-oxo-l,2,3,4- tetrahydroquinolin-6-yl)isonicotinamide. LC-MS (ES) [M+l]+ m/z: 296.1. Tl NMR (DMSO-i, 300 MHz) was consistent with a compound having the structure of 3-ethyl-N-(2- oxo-l,2,3,4-tetrahydroquinolin-6-yl)isonicotinamide. |
[ 4424-80-0 ]
4,5-Dihydro-1H-benzo[b]azepin-2(3H)-one
Similarity: 1.00
[ 120266-80-0 ]
5-Aminoindolin-2-one hydrochloride
Similarity: 0.91
[ 22246-76-0 ]
8-Amino-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one
Similarity: 0.91
[ 1175358-24-3 ]
1'H-Spiro[piperidine-4,3'-quinolin]-2'(4'H)-one hydrochloride
Similarity: 0.89
[ 22246-07-7 ]
7-Amino-3,4-dihydro-2(1H)-quinolinone
Similarity: 0.89
[ 40615-17-6 ]
3-Amino-3,4-dihydroquinolin-2(1H)-one
Similarity: 0.88